Kim Hyung Joon, Hong Sung Kyu
Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Prostate Int. 2025 Jun;13(2):74-80. doi: 10.1016/j.prnil.2024.06.002. Epub 2024 Jun 13.
A range of surgical approaches are available for treating benign prostatic hyperplasia (BPH), with emphasis placed not only on their effectiveness but also on minimizing invasiveness. The advent of surgical robotics has revolutionized BPH treatment, with robot-assisted simple prostatectomy offering a less invasive alternative to traditional approaches. The emergence of single-port systems has also earned attention for being effective in confined spaces. Aquablation represents a distinct robotic platform utilizing a heat-free, high-velocity waterjet to ablate prostate adenomas according to pre-registered configurations under real-time imaging. These novel technologies have proven to treat large prostates exceeding 80 mL efficiently and safely. Furthermore, Aquablation, along with technical modifications such as urethra-sparing robot-assisted simple prostatectomy, have demonstrated effectiveness in preserving ejaculatory function, thereby enhancing patients' overall quality of life. As evidence accumulates and technology and techniques evolve, robotic interventions for BPH may serve as a new standard in the field in the future.
有一系列手术方法可用于治疗良性前列腺增生（BPH），不仅要强调其有效性，还要尽量减少侵入性。手术机器人技术的出现彻底改变了BPH的治疗方式，机器人辅助单纯前列腺切除术为传统方法提供了一种侵入性较小的替代方案。单孔系统的出现也因其在有限空间内的有效性而受到关注。水刀消融术代表了一种独特的机器人平台，它利用无热、高速水刀根据实时成像下预先注册的配置来消融前列腺腺瘤。这些新技术已被证明能有效、安全地治疗超过80 mL的大前列腺。此外，水刀消融术以及诸如保留尿道的机器人辅助单纯前列腺切除术等技术改进，已证明在保留射精功能方面有效，从而提高了患者的整体生活质量。随着证据的积累以及技术和技巧的不断发展，未来用于BPH的机器人干预可能会成为该领域的新标准。
